Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Fumihiro Ogawa and Takeru Abe.
Fumihiro Ogawa
Connection Strength
0.870
Takeru Abe
  1. Temporal change in Syndecan-1 as a therapeutic target and a biomarker for the severity classification of COVID-19. Thromb J. 2021 Aug 16; 19(1):55.
    View in: PubMed
    Score: 0.241
  2. An evaluation of venous thromboembolism by whole-body enhanced CT scan for critical COVID-19 pneumonia with markedly rises of coagulopathy related factors: a case series study. Thromb J. 2021 Apr 20; 19(1):26.
    View in: PubMed
    Score: 0.235
  3. Environmental maintenance with effective and useful zoning to protect patients and medical staff from COVID-19 infection. Acute Med Surg. 2020 Jan-Dec; 7(1):e536.
    View in: PubMed
    Score: 0.223
  4. Combining IL-6 and SARS-CoV-2 RNAaemia-based risk stratification for fatal outcomes of COVID-19. PLoS One. 2021; 16(8):e0256022.
    View in: PubMed
    Score: 0.060
  5. Serum cholinesterase associated with COVID-19 pneumonia severity and mortality. J Infect. 2021 02; 82(2):282-327.
    View in: PubMed
    Score: 0.056
  6. Veno-venous extracorporeal membrane oxygenation for severe pneumonia: COVID-19 case in Japan. Acute Med Surg. 2020 Jan-Dec; 7(1):e509.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.